This pretest-posttest study found that patients with atypical mole syndrome have low levels of melanoma-related worry.
This case-control study found that moderate to severe pediatric atopic dermatitis may be associated with central obesity and increased systolic blood pressure. See also the Invited Commentary by Davis.
The direct-access online model results in equivalent improvements in atopic dermatitis clinical outcomes as in-person care. Direct-access online care may represent an innovative model of delivering dermatological services to patients with chronic skin diseases.
This population-based, cross-sectional study finds psoriasis to be associated with a greater likelihood of uncontrolled hypertension in a dose-dependent manner.
This open-label, nonrandomized, phase 2 clinical trial documents cutaneous adverse effects in most patients receiving cabozantinib therapy.
This cost analysis of a high-risk clinic for melanoma finds high societal costs reflecting traveling time and lost productivity, findings useful to help inform health policy for melanoma screening and treatment.
This split-body, randomized clinical trial reports significant improvement in skin texture and roughness/bumpiness but not in baseline erythema after treatment of keratosis pilaris with an 810-nm diode laser.
This case report underlines the phenotypic variability of dermatophytic infection in patients with CARD9 (caspase recruitment domain 9) protein deficiency and the potential efficacy of posaconazole.
This case report describes a patient who developed dermatomyositis following ipilimumab therapy.
This case series suggests the use of a combination of rituximab and topical corticosteroids in the treatment of pemphigus vulgaris.
This case report describes an unusual case of microemboli from the polymer coating intra-arterial stents starting months after placement and causing a panniculitis.
This consensus statement provides recommendations for the management of clinically atypical nevi and dysplastic nevi.
This summary of a Cochrane Review found that topical anti-inflammatory treatments were more effective than placebo in clearing symptoms of seborrheic dermatitis, but there are no significant differences among anti-inflammatory treatments in the short term; long-term data are lacking.